X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with VENUS REMEDIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs VENUS REMEDIES - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD VENUS REMEDIES MERCK LTD/
VENUS REMEDIES
 
P/E (TTM) x 49.0 -9.3 - View Chart
P/BV x 7.4 0.1 5,129.7% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 MERCK LTD   VENUS REMEDIES
EQUITY SHARE DATA
    MERCK LTD
Dec-16
VENUS REMEDIES
Mar-17
MERCK LTD/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs1,060143 742.3%   
Low Rs62365 958.5%   
Sales per share (Unadj.) Rs632.4324.2 195.1%  
Earnings per share (Unadj.) Rs45.76.4 713.2%  
Cash flow per share (Unadj.) Rs62.340.6 153.6%  
Dividends per share (Unadj.) Rs11.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs388.8366.0 106.2%  
Shares outstanding (eoy) m16.6012.34 134.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.30.3 415.2%   
Avg P/E ratio x18.416.2 113.6%  
P/CF ratio (eoy) x13.52.6 527.4%  
Price / Book Value ratio x2.20.3 762.3%  
Dividend payout %24.10-   
Avg Mkt Cap Rs m13,9691,282 1,089.5%   
No. of employees `0001.60.9 175.3%   
Total wages/salary Rs m1,487251 592.3%   
Avg. sales/employee Rs Th6,631.94,430.1 149.7%   
Avg. wages/employee Rs Th939.2278.0 337.9%   
Avg. net profit/employee Rs Th479.487.6 547.3%   
INCOME DATA
Net Sales Rs m10,4984,000 262.4%  
Other income Rs m24223 1,067.8%   
Total revenues Rs m10,7414,023 267.0%   
Gross profit Rs m1,135785 144.7%  
Depreciation Rs m276422 65.3%   
Interest Rs m0344 0.0%   
Profit before tax Rs m1,10242 2,618.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m343-37 -927.8%   
Profit after tax Rs m75979 959.4%  
Gross profit margin %10.819.6 55.1%  
Effective tax rate %31.1-87.9 -35.4%   
Net profit margin %7.22.0 365.6%  
BALANCE SHEET DATA
Current assets Rs m6,4102,606 245.9%   
Current liabilities Rs m8,8281,980 445.8%   
Net working cap to sales %-23.015.6 -147.3%  
Current ratio x0.71.3 55.2%  
Inventory Days Days58128 45.0%  
Debtors Days Days3843 89.0%  
Net fixed assets Rs m1,4065,353 26.3%   
Share capital Rs m166123 134.5%   
"Free" reserves Rs m6,2864,393 143.1%   
Net worth Rs m6,4554,516 142.9%   
Long term debt Rs m01,618 0.0%   
Total assets Rs m8,8288,291 106.5%  
Interest coverage xNM1.1-  
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.20.5 246.5%   
Return on assets %8.65.1 168.6%  
Return on equity %11.81.8 671.3%  
Return on capital %17.16.3 271.5%  
Exports to sales %8.30-   
Imports to sales %21.018.4 114.3%   
Exports (fob) Rs m869NA-   
Imports (cif) Rs m2,209736 300.0%   
Fx inflow Rs m9590-   
Fx outflow Rs m2,612736 354.7%   
Net fx Rs m-1,653-736 224.5%   
CASH FLOW
From Operations Rs m1,070997 107.3%  
From Investments Rs m-750-461 162.5%  
From Financial Activity Rs m-150-571 26.2%  
Net Cashflow Rs m171-35 -486.9%  

Share Holding

Indian Promoters % 0.0 32.9 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 0.2 10,111.1%  
FIIs % 1.0 0.6 172.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 66.4 43.8%  
Shareholders   28,591 20,121 142.1%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   WYETH LTD  IPCA LABS  JUBILANT LIFE SCIENCES  AUROBINDO PHARMA  PIRAMAL ENTERPRISES  

Compare MERCK LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Nifty Crosses 11,500-Mark; L&T Surges 4% on Buyback News(09:30 am)

Asian stock markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.2% while the Hang Seng is up 0.7%.

Related Views on News

MERCK LTD Announces Quarterly Results (1QFY19); Net Profit Up 63.1% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, MERCK LTD has posted a net profit of Rs 328 m (up 63.1% YoY). Sales on the other hand came in at Rs 2 bn (down 17.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (4QFY18); Net Profit Up 53.2% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, MERCK LTD has posted a net profit of Rs 227 m (up 53.2% YoY). Sales on the other hand came in at Rs 3 bn (up 27.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Only on WhatsApp, a Weaker Rupee Means a Weaker India(Vivek Kaul's Diary)

Aug 16, 2018

While dollar crossing Rs 70 will have its repercussions, the world isn't exactly coming to an end.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Aug 20, 2018 10:41 AM

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - AUROBINDO PHARMA COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS